The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Perivascular microglia activation is a hallmark of inflammatory demyelination in multiple sclerosis (MS), but the mechanisms underlying microglia activation and specific strategies to attenuate their activation remain elusive. Here, we identify fibrinogen as a novel regulator of microglia activation and show that targeting of the interaction of fibrinogen with the microglia integrin receptor Mac-1 (alpha(M)beta(2), CD11b/CD18) is sufficient to suppress experimental autoimmune encephalomyelitis in mice that retain full coagulation function. We show that fibrinogen, which is deposited perivascularly in MS plaques, signals through Mac-1 and induces the differentiation of microglia to phagocytes via activation of Akt and Rho. Genetic disruption of fibrinogen-Mac-1 interaction in fibrinogen-gamma(390-396A) knock-in mice or pharmacologically impeding fibrinogen-Mac-1 interaction through intranasal delivery of a fibrinogen-derived inhibitory peptide (gamma(377-395)) attenuates microglia activation and suppresses relapsing paralysis. Because blocking fibrinogen-Mac-1 interactions affects the proinflammatory but not the procoagulant properties of fibrinogen, targeting the gamma(377-395) fibrinogen epitope could represent a potential therapeutic strategy for MS and other neuroinflammatory diseases associated with blood-brain barrier disruption and microglia activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Fibγ390-396A mice have reduced clinical scores and microglia activation in EAE. (A) Clinical scores of MOG35-55–immunized mice. Fibγ390-396A mice (blue triangles; n = 29) show statistically significant lower clinical scores (*, P < 0.01) than FibγWT control mice (black squares; n = 28). (B) Individual clinical scores from Fibγ390-396A and FibγWT mice on days 20 (average clinical score, 3.3 ± 0.22 for FibγWT [n = 19] vs. 2.1 ± 0.32 for Fibγ390-396A [n = 20]; P < 0.01) and 31 after immunization (average clinical score, 2.8 ± 0.25 for FibγWT [n = 15] vs. 1.5 ± 0.23 for Fibγ390-396A [n = 20]; P < 0.001). (C) Histological analysis of spinal cord sections stained with hematoxylin/eosin revealed increased inflammation in the FibγWT mice versus the Fibγ390-396A mice. (D) Survival curve of Fibγ390-396A and FibγWT mice after MOG35-55 immunization. Fibγ390-396A had a greater survival rate than the FibγWT mice. (E) Rotarod analysis of Fibγ390-396A and FibγWT mice on day 13. Fibγ390-396A significantly outperformed their wild-type counterparts in a behavioral test designed to assess motor skill function. n = 7 mice per group. **, P < 0.05. (F) Increased activation of IsoB4+ cells in FibγWT mice as compared with Fibγ390-396A mice. Bar, 58 μm. Data are represented as the mean clinical score and are mean ± SEM.](https://figures.cochat.ai/paper-figures/a0547757dbd947b08e158d353bae9525/the-fibrin-derived-377-395-peptide-inhibits-microglia-activation-and-suppresses-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fggγ390–396A knock-in mice, which express fully coagulable fibrinogen that selectively lacks the CD11b receptor binding site (Adams et al., 2007; Flick et al., 2004).”
From Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model (2019) · cites this paper as Adams et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Moreover, in vivo live imaging showed that BBB disruption provokes the immediate and focal activation of microglia (7).”
BackgroundNew Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“For peptide- recognizing integrin receptors, such as the RGD-recognizing αvβ3 and α5β1 integrins, both the peptide itself and antibodies against the peptide may inhibit integrin-mediated biological eff ects (49-52).”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“The CD11c+ perivascular dendritic cells are responsible for the presentation of myelin antigens (58, 59).”
Background
Cited by
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
“In contrast to most other macrophages, these cells are shielded from serum proteins that might lead to their activation, and there is evidence that serum constituents can selectively and potently activate macrophages (68).”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Self-citationWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804
“This concept was rendered more specific and able to be molecularly dissected with the demonstration that plasma fibrinoge”
BackgroundThe blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 754
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733
“In the healthy CNS, these proteins are confined to the vasculature, and their leakage into the parenchyma has been widely used as an endogenous marker of BBB disruption (8, 11, 17).”
BackgroundThe biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655
Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
Chodobski, A., Zink, B. J., & Szmydynger-Chodobska, J. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0125-x · Cited by 650
Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and Intervention Strategies
Kozai, T. D. Y., Jaquins-Gerstl, A. S., Vazquez, A. L., Michael, A. C., & Cui, X. T. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500256e · Cited by 622
Davalos, D., Kyu Ryu, J., Merlini, M., Baeten, K. M., Le Moan, N., Petersen, M. A., Deerinck, T. J., Smirnoff, D. S., Bedard, C., Hakozaki, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2230 · Cited by 568
Self-citationThe multifaceted role of fibrinogen in tissue injury and inflammation
Luyendyk, J. P., Schoenecker, J. G., & Flick, M. J. (2019) · Blood · doi:10.1182/blood-2018-07-818211 · Cited by 555
Self-citationFibrinogen in neurological diseases: mechanisms, imaging and therapeutics
Petersen, M. A., Ryu, J. K., & Akassoglou, K. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2018.13 · Cited by 527
Self-citationMerlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
Self-citationApolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412
Ryu, J. K., & McLarnon, J. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00434.x · Cited by 406
“Both premises were examined using anti-Mac-1 antibody, which binds to the same microglial CD11b/CD18 integrin as does fibrinogen [22, 31].”
MethodExtracellular matrix and matrix receptors in blood–brain barrier formation and stroke
Baeten, K. M., & Akassoglou, K. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20954 · Cited by 397
“A study in our laboratory by Adams et al. (2007a) shows that the binding of fibrin to aMb2 on microglia results in microglia activation, which is characterized by an increase in cell size and induction of phagocytosis.”
BackgroundInfluentialSelf-citationSchachtrup, C., Ryu, J. K., Helmrick, M. J., Vagena, E., Galanakis, D. K., Degen, J. L., Margolis, R. U., & Akassoglou, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0137-10.2010 · Cited by 370
Self-citationMontagne, A., Nikolakopoulou, A. M., Zhao, Z., Sagare, A. P., Si, G., Lazic, D., Barnes, S. R., Daianu, M., Ramanathan, A., Go, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4482 · Cited by 344
RetractedJordão, J. F., Thévenot, E., Markham-Coultes, K., Scarcelli, T., Weng, Y.-Q., Xhima, K., O'Reilly, M., Huang, Y., McLaurin, J., Hynynen, K., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.05.008 · Cited by 326
Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity
Kraft, A. D., & Harry, G. J. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8072980 · Cited by 326
Groves, A., Kihara, Y., & Chun, J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.02.011 · Cited by 314
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
Self-citationMicroglia–blood vessel interactions: a double-edged sword in brain pathologies
Dudvarski Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F., & Schmidt, M. H. H. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1524-y · Cited by 301
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007) · Brain · doi:10.1093/brain/awm236 · Cited by 292
Self-citationNeuroinflammation after surgery: from mechanisms to therapeutic targets
Yang, T., Velagapudi, R., & Terrando, N. (2020) · Nature Immunology · doi:10.1038/s41590-020-00812-1 · Cited by 274
Ryu, J. K., Petersen, M. A., Murray, S. G., Baeten, K. M., Meyer-Franke, A., Chan, J. P., Vagena, E., Bedard, C., Machado, M. R., Coronado, P. E. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9164 · Cited by 271
Self-citationThe role of antigen presenting cells in multiple sclerosis
Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 266
Perivascular microglia promote blood vessel disintegration in the ischemic penumbra
Jolivel, V., Bicker, F., Binamé, F., Ploen, R., Keller, S., Gollan, R., Jurek, B., Birkenstock, J., Poisa-Beiro, L., Bruttger, J., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1372-1 · Cited by 265
Bridging barriers: a comparative look at the blood–brain barrier across organisms
O'Brown, N. M., Pfau, S. J., & Gu, C. (2018) · Genes & Development · doi:10.1101/gad.309823.117 · Cited by 263
Microglia and neuroprotection: From in vitro studies to therapeutic applications
Polazzi, E., & Monti, B. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.009 · Cited by 262
Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway
Vidal, B., Serrano, A. L., Tjwa, M., Suelves, M., Ardite, E., De Mori, R., Baeza-Raja, B., Martínez de Lagrán, M., Lafuste, P., Ruiz-Bonilla, V., et al. (2008) · Genes & Development · doi:10.1101/gad.465908 · Cited by 257
Self-citationMicroglia in the developing brain: a potential target with lifetime effects
Harry, G. J., & Kraft, A. D. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.012 · Cited by 250
“In addition to the secondary contribution of cells from the circulating blood, components of plasma such as fibrinogen can, in and of themselves, initiate a response of microglia (Adams et al., 2007; Ransohoff and Perry, 2009; Ryu et al., 2009).”
Novel Aspects of Fibrin(ogen) Fragments during Inflammation
Jennewein, C., Tran, N., Paulus, P., Ellinghaus, P., Eble, J. A., & Zacharowski, K. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00146 · Cited by 248
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Horng, S., Therattil, A., Moyon, S., Gordon, A., Kim, K., Argaw, A. T., Hara, Y., Mariani, J. N., Sawai, S., Flodby, P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91301 · Cited by 221
Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen
Hsieh, J. Y., Smith, T. D., Meli, V. S., Tran, T. N., Botvinick, E. L., & Liu, W. F. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.024 · Cited by 219
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0232-x · Cited by 213
Self-citationFactor XIII activity mediates red blood cell retention in venous thrombi
Aleman, M. M., Byrnes, J. R., Wang, J.-G., Tran, R., Lam, W. A., Di Paola, J., Mackman, N., Degen, J. L., Flick, M. J., & Wolberg, A. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75386 · Cited by 211
Self-citationNishioku, T., Dohgu, S., Takata, F., Eto, T., Ishikawa, N., Kodama, K. B., Nakagawa, S., Yamauchi, A., & Kataoka, Y. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9322-x · Cited by 210
Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization
Ahn, H. J., Zamolodchikov, D., Cortes-Canteli, M., Norris, E. H., Glickman, J. F., & Strickland, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010373107 · Cited by 209
Petersen, M. A., Ryu, J. K., Chang, K.-J., Etxeberria, A., Bardehle, S., Mendiola, A. S., Kamau-Devers, W., Fancy, S. P. J., Thor, A., Bushong, E. A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.008 · Cited by 201
Self-citationTranscriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
Mendiola, A. S., Ryu, J. K., Bardehle, S., Meyer-Franke, A., Ang, K. K.-H., Wilson, C., Baeten, K. M., Hanspers, K., Merlini, M., Thomas, S., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0654-0 · Cited by 199
Self-citationGöbel, K., Eichler, S., Wiendl, H., Chavakis, T., Kleinschnitz, C., & Meuth, S. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01731 · Cited by 193
Chapouly, C., Tadesse Argaw, A., Horng, S., Castro, K., Zhang, J., Asp, L., Loo, H., Laitman, B. M., Mariani, J. N., Straus Farber, R., et al. (2015) · Brain · doi:10.1093/brain/awv077 · Cited by 190
Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier
Silva, L. M., Doyle, A. D., Greenwell-Wild, T., Dutzan, N., Tran, C. L., Abusleme, L., Juang, L. J., Leung, J., Chun, E. M., Lum, A. G., et al. (2021) · Science · doi:10.1126/science.abl5450 · Cited by 189
Self-citationEffects of Microglia on Neurogenesis
Sato, K. (2015) · Glia · doi:10.1002/glia.22858 · Cited by 187
The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis
Ghorbani, S., & Yong, V. W. (2021) · Brain · doi:10.1093/brain/awab059 · Cited by 183
Thurgur, H., & Pinteaux, E. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.046 · Cited by 176
Haslund‐Vinding, J., McBean, G., Jaquet, V, & Vilhardt, F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13425 · Cited by 169
Nishioku, T., Matsumoto, J., Dohgu, S., Sumi, N., Miyao, K., Takata, F., Shuto, H., Yamauchi, A., & Kataoka, Y. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09292sc · Cited by 168
Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
Wang, F., Cao, Y., Ma, L., Pei, H., Rausch, W. D., & Li, H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00376 · Cited by 157
Fibrinolysis and Inflammation in Venous Thrombus Resolution
Mukhopadhyay, S., Johnson, T. A., Duru, N., Buzza, M. S., Pawar, N. R., Sarkar, R., & Antalis, T. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01348 · Cited by 164
“On the other hand, studies with fibrinogen-γ390−396A knock-in mice identified the CD11b/CD18 integrin as the primary receptor for the fibrin mediated pro-inflammatory macrophage cytokine secretion (93).”
BackgroundSharma, R., Fischer, M.-T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., Fujihara, K., Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0704-z · Cited by 164
Self-citationMechanical disruption of the blood–brain barrier following experimental concussion
Johnson, V. E., Weber, M. T., Xiao, R., Cullen, D. K., Meaney, D. F., Stewart, W. B., Jr., & Smith, D. H. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1824-0 · Cited by 169
Steinbrecher, K. A., Horowitz, N. A., Blevins, E. A., Barney, K. A., Shaw, M. A., Harmel-Laws, E., Finkelman, F. D., Flick, M. J., Pinkerton, M. D., Talmage, K. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3465 · Cited by 174
Self-citationFornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
SIRT1 deacetylates RORγt and enhances Th17 cell generation
Lim, H. W., Kang, S. G., Ryu, J. K., Schilling, B., Fei, M., Lee, I. S., Kehasse, A., Shirakawa, K., Yokoyama, M., Schnölzer, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132378 · Cited by 148
Self-citationPreactive lesions in multiple sclerosis
van der Valk, P., & Amor, S. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c76 · Cited by 156
Rasmussen, S., Wang, Y., Kivisäkk, P., Bronson, R. T., Meyer, M., Imitola, J., & Khoury, S. J. (2007) · Brain · doi:10.1093/brain/awm219 · Cited by 154
“Inhibition of persistent microglia activation may prolong the life span of the mice in models of neurodegeneration (Heppner et al., 2005; Adams et al., 2007; Qin et al., 2007; Yoshiyama et al., 2007).”
BackgroundA Developmental Analysis of Juxtavascular Microglia Dynamics and Interactions with the Vasculature
Mondo, E., Becker, S. C., Kautzman, A. G., Schifferer, M., Baer, C. E., Chen, J., Huang, E. J., Simons, M., & Schafer, D. P. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.3006-19.2020 · Cited by 159
Role of microglia in neuronal degeneration and regeneration
Walter, L. M., & Neumann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0180-5 · Cited by 168
The role of microglia in human disease: therapeutic tool or target?
Cartier, N., Lewis, C.-A., Zhang, R., & Rossi, F. M. V. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1330-y · Cited by 136
Blood–brain barrier and traumatic brain injury
Alves, J. L. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23300 · Cited by 137
CNS sterile injury: just another wound healing?
Shechter, R., & Schwartz, M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.007 · Cited by 152
Kozai, T. D. Y., Li, X., Bodily, L. M., Caparosa, E. M., Zenonos, G. A., Carlisle, D. L., Friedlander, R. M., & Cui, X. T. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.006 · Cited by 136
Thrombin promotes diet-induced obesity through fibrin-driven inflammation
Kopec, A. K., Abrahams, S. R., Thornton, S., Palumbo, J. S., Mullins, E. S., Divanovic, S., Weiler, H., Owens, A. P., Mackman, N., Goss, A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92744 · Cited by 125
Self-citationA critical role for plasminogen in inflammation
Baker, S. K., & Strickland, S. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191865 · Cited by 138
Göbel, K., Pankratz, S., Asaridou, C.-M., Herrmann, A. M., Bittner, S., Merker, M., Ruck, T., Glumm, S., Langhauser, F., Kraft, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11626 · Cited by 131
Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia
Wang, P., Velagapudi, R., Kong, C., Rodriguiz, R. M., Wetsel, W. C., Yang, T., Berger, M., Gelbard, H. A., Colton, C. A., & Terrando, N. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12064 · Cited by 118
Hu, X., Zhang, D., Pang, H., Caudle, W. M., Li, Y., Gao, H., Liu, Y., Qian, L., Wilson, B., Di Monte, D. A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7194 · Cited by 125
SIRT1 deacetylates RORγt and enhances Th17 cell generation
Lim, H. W., Kang, S. G., Ryu, J. K., Schilling, B., Fei, M., Lee, I. S., Kehasse, A., Shirakawa, K., Yokoyama, M., Schnölzer, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.2013237805062015c · Cited by 122
Self-citationDefining blood-induced microglia functions in neurodegeneration through multiomic profiling
Mendiola, A. S., Yan, Z., Dixit, K., Johnson, J. R., Bouhaddou, M., Meyer-Franke, A., Shin, M.-G., Yong, Y., Agrawal, A., MacDonald, E., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01522-0 · Cited by 124
Self-citationNeuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System
De Luca, C., Colangelo, A. M., Alberghina, L., & Papa, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00459 · Cited by 118
Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis
Gaultier, A., Wu, X., Le Moan, N., Takimoto, S., Mukandala, G., Akassoglou, K., Campana, W. M., & Gonias, S. L. (2009) · Journal of Cell Science · doi:10.1242/jcs.040717 · Cited by 118
Self-citationFibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor
Schachtrup, C., Lu, P., Jones, L. L., Lee, J. K., Lu, J., Sachs, B. D., Zheng, B., & Akassoglou, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704045104 · Cited by 117
Self-citationLuo, S., Ma, C., Zhu, M.-Q., Ju, W.-N., Yang, Y., & Wang, X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00021 · Cited by 109
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano-Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 91
Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
Yates, R. L., Esiri, M. M., Palace, J., Jacobs, B., Perera, R., & DeLuca, G. C. (2017) · Annals of Neurology · doi:10.1002/ana.24997 · Cited by 112
Fibrinogen signal transduction in the nervous system
RYU, J. K., DAVALOS, D., & AKASSOGLOU, K. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03438.x · Cited by 106
Self-citationVega‐Pérez, A., Villarrubia, L. H., Godio, C., Gutiérrez‐González, A., Feo-Lucas, L., Ferriz, M., Martínez‐Puente, N., Alcaín, J., Mora, A., Sabio, G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.007 · Cited by 126
Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury
Akhmetzyanova, E. R., Kletenkov, K., Mukhamedshina, Y. O., & Rizvanov, A. A. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2019.00037 · Cited by 115
Vascular dementia: A microglia's perspective
Yang, Y. R., Zhao, X., Zhu, Z., & Zhang, L. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101734 · Cited by 118
An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111
Ko, Y., & Flick, M. J. (2016) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1579635 · Cited by 113
Self-citationHu, X., Zhou, H., Zhang, D., Yang, S., Qian, L., Wu, H.-M., Chen, P.-S., Wilson, B., Gao, H.-M., Lu, R.-B., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9309-0 · Cited by 102
Ahn, H. J., Glickman, J. F., Poon, K. L., Zamolodchikov, D., Jno-Charles, O. C., Norris, E. H., & Strickland, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131751 · Cited by 100
Effects of Biologic Scaffolds on Human Stem Cells and Implications for CNS Tissue Engineering
Crapo, P. M., Tottey, S., Slivka, P. F., & Badylak, S. F. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0186 · Cited by 103
A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord
Halder, S. K., & Milner, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912178116 · Cited by 96
The current status of biomarkers for predicting toxicity
Campion, S., Aubrecht, J., Boekelheide, K., Brewster, D. W., Vaidya, V. S., Anderson, L., Burt, D., Dere, E., Hwang, K., Pacheco, S., et al. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.827170 · Cited by 97
Early detection of thrombin activity in neuroinflammatory disease
Davalos, D., Baeten, K. M., Whitney, M. A., Mullins, E. S., Friedman, B., Olson, E. S., Ryu, J. K., Smirnoff, D. S., Petersen, M. A., Bedard, C., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24078 · Cited by 97
Self-citationFlick, M. J., Du, X., Prasad, J. M., Raghu, H., Palumbo, J. S., Smeds, E., Höök, M., & Degen, J. L. (2013) · Blood · doi:10.1182/blood-2012-09-453894 · Cited by 95
Self-citationSix, A., Bellais, S., Bouaboud, A., Fouet, A., Gabriel, C., Tazi, A., Dramsi, S., Trieu‐Cuot, P., & Poyart, C. (2015) · Molecular Microbiology · doi:10.1111/mmi.13097 · Cited by 83
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo
Munks, M. W., McKee, A. S., MacLeod, M. K. L., Powell, R. L., Degen, J. L., Reisdorph, N. A., Kappler, J. W., & Marrack, P. (2010) · Blood · doi:10.1182/blood-2010-03-275529 · Cited by 93
Self-citationCan we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & Kerlero de Rosbo, N. (2014) · Immunology · doi:10.1111/imm.12177 · Cited by 85
Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
Abrahamson, E. E., & Ikonomovic, M. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113257 · Cited by 86
Natural killer cells and their receptors in multiple sclerosis
Kaur, G., Trowsdale, J., & Fugger, L. (2013) · Brain · doi:10.1093/brain/aws159 · Cited by 85
Glucocorticoids in the control of neuroinflammation
Tischner, D., & Reichardt, H. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.03.007 · Cited by 103
Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions
Ogbodo, J. O., Agbo, C. P., Njoku, U. O., Ogugofor, M. O., Egba, S. I., Ihim, S. A., Echezona, A. C., Brendan, K. C., Upaganlawar, A. B., & Upasani, C. D. (2022) · Current Aging Science · doi:10.2174/1874609814666210302085232 · Cited by 78
Meinl, E., Krumbholz, M., Derfuss, T. J., Junker, A., & Hohlfeld, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.032 · Cited by 96
Metadata
- Authors
- Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K.
- Affiliations
- University of California San Diego (US)
- Medical University of Vienna (AT)
- University of Cincinnati (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-03-05
- Volume
- 204
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2137908
- OpenAlex
- W2142424019
- Cited by
- 335
- References
- 72
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 19 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS052189, P30NS047101, R01NS051470)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- fibrinogen, microglial activation, Mac-1, CD11b/CD18, multiple sclerosis, experimental autoimmune encephalomyelitis, inflammatory demyelination, Akt signaling, Rho GTPase signaling, blood-brain barrier disruption, neuroinflammation
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Female, Fibrin, Fibrinogen, Mice, Inbred C57BL, Molecular Sequence Data, Peptide Fragments, Macrophage-1 Antigen, Microglia, Multiple Sclerosis, Relapsing-Remitting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.